David Hovda

David Hovda

Directeur/Membre du Conseil chez PRO-DEX, INC.

Fortune : 251 851 $ au 31/07/2026

64 ans
Health Technology
Consumer Services
Government

Profil

David C.
Hovda
currently serves as Independent Director at Pro-Dex, Inc. since 2013, Director at CurvaFix, Inc. since 2021, and President of Medtech Advisors, Inc. Former roles include President, Chief Executive Officer & Director at SpinalMotion, Inc. from 2004 to 2013; President, Chief Executive Officer & Director at Simplify Medical, Inc. from 2013 to 2021; Chief Executive Officer at Innovein, Inc. from 2022 to 2023; Chief Executive Officer & Secretary at Versa Vascular, Inc.; European Business Manager-Upper Airway Venture at Medtronic, Inc. from 1995 to 1997; Vice President & General Manager-Spine Division at Arthrocare Corp.
from 1999 to 2004; and Principal at the US Department of the Navy (District of Columbia).
Education includes undergraduate studies at Northwestern University and an MBA from Harvard Business School.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
20/11/2025 4 300 ( 0,13% ) 251 851 $ 31/07/2026

Postes actifs de David Hovda

SociétésPosteDébut
PRO-DEX, INC. Directeur/Membre du Conseil 17/01/2013
Directeur/Membre du Conseil 01/04/2021
Medtech Advisors, Inc.
President -

Anciens postes connus de David Hovda

SociétésPosteFin
Directeur Général 01/08/2023
Directeur Général 01/01/2021
Directeur Général 01/01/2013
ARTHROCARE CORPORATION Corporate Officer/Principal 01/01/2004
Voir l'expérience en détail de David Hovda

Formation de David Hovda

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

59

Relations au 1er degré

11

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées11

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Government

Consumer Services

Health Technology

Medtech Advisors, Inc.

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. David Hovda